ATRX and type 2 diabetes mellitus: Clonogenic assays with the RAD54-T2A/D mutants showed that T2D mutant had higher survival capacity than T2A after IR, MMC or Olaparib induced damage that was comparable to that of WT reconstituted cells (Figure 2G–I, Supplementary Figure S8B, C).